Sign In

Login

Password

Forgot Password ? Sign Up

Schizofrenie (Czech Wikipedia)

Analysis of information sources in references of the Wikipedia article "Schizofrenie" in Czech language version.

refsWebsite
Global rank Czech rank
85nih.gov
4th place
8th place
73doi.org
2nd place
4th place
6books.google.com
3rd place
25th place
5web.archive.org
1st place
1st place
2cochrane.org
7,609th place
low place
1uzis.cz
low place
568th place
1ordinace.cz
low place
649th place
1psychicus.cz
low place
low place
1maastrichtuniversity.nl
low place
low place
1oxfordreference.com
938th place
1,963rd place
1yimg.com
low place
low place
1kluweronline.com
low place
low place
1emedicine.com
3,595th place
3,426th place
1psychiatrictimes.com
9,815th place
low place
1behavenet.com
low place
low place
1psychiatryonline.org
4,032nd place
4,117th place
1nice.org.uk
3,258th place
9,541st place
1elsevierhealth.com
low place
low place
1brown.uk.com
low place
low place
1who.int
195th place
168th place

behavenet.com

  • American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV. Washington, DC: American Psychiatric Publishing, Inc., 2000. ISBN 0-89042-024-6. Kapitola Schizophrenia. 

books.google.com

brown.uk.com

cochrane.org

doi.org

dx.doi.org

  • van Os J, Kapur S. Schizophrenia. Lancet. 2009, s. 635–45. Dostupné v archivu pořízeném dne 2013-06-23. DOI 10.1016/S0140-6736(09)60995-8. PMID 19700006.  Archivovaná kopie. xa.yimg.com [online]. [cit. 2014-11-09]. Dostupné v archivu pořízeném z originálu dne 2013-06-23. 
  • Picchioni MM, Murray RM. Schizophrenia. BMJ. 2007, s. 91–5. DOI 10.1136/bmj.39227.616447.BE. PMID 17626963. 
  • Becker T, Kilian R. Psychiatric services for people with severe mental illness across western Europe: what can be generalized from current knowledge about differences in provision, costs and outcomes of mental health care?. Acta Psychiatrica Scandinavica Supplement. 2006, s. 9–16. DOI 10.1111/j.1600-0447.2005.00711.x. PMID 16445476. 
  • Buckley PF, Miller BJ, Lehrer DS, Castle DJ. Psychiatric comorbidities and schizophrenia. Schizophr Bull. 2009, s. 383–402. DOI 10.1093/schbul/sbn135. PMID 19011234. 
  • Kuhn R. Eugen Bleuler's concepts of psychopathology. Tr. Cahn CH. History of Psychiatry. 2004, s. 361–6. DOI 10.1177/0957154X04044603. PMID 15386868. 
  • Stotz-Ingenlath G. Epistemological aspects of Eugen Bleuler's conception of schizophrenia in 1911. Medicine, Health Care and Philosophy. 2000, s. 153–9. Dostupné online. DOI 10.1023/A:1009919309015. PMID 11079343. 
  • Brunet-Gouet E, Decety J. Social brain dysfunctions in schizophrenia: a review of neuroimaging studies. Psychiatry Res. 2006, s. 75–92. DOI 10.1016/j.pscychresns.2006.05.001. PMID 17088049. 
  • Ungvari GS, Caroff SN, Gerevich J. The catatonia conundrum: evidence of psychomotor phenomena as a symptom dimension in psychotic disorders. Schizophr Bull. 2010, s. 231–8. DOI 10.1093/schbul/sbp105. PMID 19776208. 
  • Addington J, Cadenhead KS, Cannon TD, et al.. North American prodrome longitudinal study: a collaborative multisite approach to prodromal schizophrenia research. Schizophrenia Bulletin. 2007, s. 665–72. DOI 10.1093/schbul/sbl075. PMID 17255119. 
  • Amminger GP, Leicester S, Yung AR, et al.. Early onset of symptoms predicts conversion to non-affective psychosis in ultra-high risk individuals. Schizophrenia Research. 2006, s. 67–76. DOI 10.1016/j.schres.2006.02.018. PMID 16677803. 
  • FAZEL, S, Gulati, G, Linsell, L, Geddes, JR, Grann, M. Schizophrenia and Violence: Systematic Review and Meta-Analysis. Redakce McGrath John. PLoS medicine. August 2009, s. e1000120. DOI 10.1371/journal.pmed.1000120. PMID 19668362. 
  • LARGE, M, Smith, G, Nielssen, O. The relationship between the rate of homicide by those with schizophrenia and the overall homicide rate: a systematic review and meta-analysis. Schizophrenia research. July 2009, s. 123–9. DOI 10.1016/j.schres.2009.04.004. PMID 19457644. 
  • Nordgaard J, Arnfred SM, Handest P, Parnas J. The diagnostic status of first-rank symptoms. Schizophrenia Bulletin. 2008, s. 137–54. DOI 10.1093/schbul/sbm044. PMID 17562695. 
  • Drake RJ, Lewis SW. Early detection of schizophrenia. Current Opinion in Psychiatry. 2005, s. 147–50. DOI 10.1097/00001504-200503000-00007. PMID 16639167. 
  • O'Donovan MC, Williams NM, Owen MJ. Recent advances in the genetics of schizophrenia. Hum. Mol. Genet.. 2003, s. R125–33. DOI 10.1093/hmg/ddg302. PMID 12952866. 
  • McLaren JA, Silins E, Hutchinson D, Mattick RP, Hall W. Assessing evidence for a causal link between cannabis and psychosis: a review of cohort studies. Int. J. Drug Policy. 2010, s. 10–9. DOI 10.1016/j.drugpo.2009.09.001. PMID 19783132. 
  • O'Donovan MC, Craddock NJ, Owen MJ. Genetics of psychosis; insights from views across the genome. Hum. Genet.. 2009, s. 3–12. DOI 10.1007/s00439-009-0703-0. PMID 19521722. 
  • Craddock N, Owen MJ. The Kraepelinian dichotomy - going, going... But still not gone. The British Journal of Psychiatry. 2010, s. 92–95. DOI 10.1192/bjp.bp.109.073429. PMID 20118450. 
  • Crow TJ. The 'big bang' theory of the origin of psychosis and the faculty of language. Schizophrenia Research. 2008, s. 31–52. DOI 10.1016/j.schres.2008.03.010. PMID 18502103. 
  • Van Os J. Does the urban environment cause psychosis?. British Journal of Psychiatry. 2004, s. 287–288. DOI 10.1192/bjp.184.4.287. PMID 15056569. 
  • Selten JP, Cantor-Graae E, Kahn RS. Migration and schizophrenia. Current Opinion in Psychiatry. 2007, s. 111–115. DOI 10.1097/YCO.0b013e328017f68e. PMID 17278906. 
  • Gregg L, Barrowclough C, Haddock G. Reasons for increased substance use in psychosis. Clin Psychol Rev. 2007, s. 494–510. DOI 10.1016/j.cpr.2006.09.004. PMID 17240501. 
  • Leweke FM, Koethe D. Cannabis and psychiatric disorders: it is not only addiction. Addict Biol. 2008, s. 264–75. DOI 10.1111/j.1369-1600.2008.00106.x. PMID 18482435. 
  • Moore THM, Zammit S, Lingford-Hughes A et al.. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet. 2007, s. 319–328. DOI 10.1016/S0140-6736(07)61162-3. PMID 17662880. 
  • SEWELL, RA, Ranganathan, M, D'Souza, DC. Cannabinoids and psychosis. International review of psychiatry (Abingdon, England). 2009 Apr, s. 152–62. DOI 10.1080/09540260902782802. PMID 19367509. 
  • HENQUET, C, Di Forti, M, Morrison, P, Kuepper, R, Murray, RM. Gene-Environment Interplay Between Cannabis and Psychosis. Schizophrenia bulletin. 2008 Nov, s. 1111–21. DOI 10.1093/schbul/sbn108. PMID 18723841. 
  • Ben Amar M, Potvin S. Cannabis and psychosis: what is the link?. Journal of psychoactive drugs. 2007 Jun, s. 131–42. DOI 10.1080/02791072.2007.10399871. PMID 17703707. 
  • Broome MR, Woolley JB, Tabraham P, et al.. What causes the onset of psychosis?. Schizophr. Res.. 2005, s. 23–34. DOI 10.1016/j.schres.2005.02.007. PMID 16198238. 
  • Bentall RP, Fernyhough C, Morrison AP, Lewis S, Corcoran R. Prospects for a cognitive-developmental account of psychotic experiences. Br J Clin Psychol. 2007, s. 155–73. DOI 10.1348/014466506X123011. PMID 17524210. 
  • Kurtz MM. Neurocognitive impairment across the lifespan in schizophrenia: an update. Schizophrenia Research. 2005, s. 15–26. DOI 10.1016/j.schres.2004.07.005. PMID 15694750. 
  • Cohen AS, Docherty NM. Affective reactivity of speech and emotional experience in patients with schizophrenia. Schizophrenia Research. 2004, s. 7–14. DOI 10.1016/S0920-9964(03)00069-0. PMID 15145465. 
  • Horan WP, Blanchard JJ. Emotional responses to psychosocial stress in schizophrenia: the role of individual differences in affective traits and coping. Schizophrenia Research. 2003, s. 271–83. DOI 10.1016/S0920-9964(02)00227-X. PMID 12591589. 
  • Smith B, Fowler DG, Freeman D,et al.. Emotion and psychosis: links between depression, self-esteem, negative schematic beliefs and delusions and hallucinations. Schizophr. Res.. 2006, s. 181–8. DOI 10.1016/j.schres.2006.06.018. PMID 16857346. 
  • Beck, AT. A Cognitive Model of Schizophrenia. Journal of Cognitive Psychotherapy. 2004, s. 281–88. DOI 10.1891/jcop.18.3.281.65649. 
  • Bell V, Halligan PW, Ellis HD. Explaining delusions: a cognitive perspective. Trends in Cognitive Science. 2006, s. 219–26. DOI 10.1016/j.tics.2006.03.004. PMID 16600666. 
  • Freeman D, Garety PA, Kuipers E, Fowler D, Bebbington PE, Dunn G. Acting on persecutory delusions: the importance of safety seeking. Behav Res Ther. 2007, s. 89–99. DOI 10.1016/j.brat.2006.01.014. PMID 16530161. 
  • Kuipers E, Garety P, Fowler D, Freeman D, Dunn G, Bebbington P. Cognitive, emotional, and social processes in psychosis: refining cognitive behavioral therapy for persistent positive symptoms. Schizophr Bull. 2006, s. S24–31. DOI 10.1093/schbul/sbl014. PMID 16885206. 
  • Insel TR. Rethinking schizophrenia. Nature. 2010, s. 187–93. DOI 10.1038/nature09552. PMID 21068826. 
  • Laruelle M, Abi-Dargham A, van Dyck CH, et al.. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc. Natl. Acad. Sci. U.S.A.. 1996, s. 9235–40. DOI 10.1073/pnas.93.17.9235. PMID 8799184. 
  • Jones HM, Pilowsky LS. Dopamine and antipsychotic drug action revisited. British Journal of Psychiatry. 2002, s. 271–275. DOI 10.1192/bjp.181.4.271. PMID 12356650. 
  • Konradi C, Heckers S. Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment. Pharmacology and Therapeutics. 2003, s. 153–79. DOI 10.1016/S0163-7258(02)00328-5. PMID 12559388. 
  • Lahti AC, Weiler MA, Tamara Michaelidis BA, Parwani A, Tamminga CA. Effects of ketamine in normal and schizophrenic volunteers. Neuropsychopharmacology. 2001, s. 455–67. DOI 10.1016/S0893-133X(01)00243-3. PMID 11557159. 
  • Coyle JT, Tsai G, Goff D. Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia. Annals of the New York Academy of Sciences. 2003, s. 318–27. DOI 10.1196/annals.1300.020. PMID 14684455. 
  • Tuominen HJ, Tiihonen J, Wahlbeck K. Glutamatergic drugs for schizophrenia: a systematic review and meta-analysis. Schizophrenia Research. 2005, s. 225–34. DOI 10.1016/j.schres.2004.05.005. PMID 15560967. 
  • Jakobsen KD, Frederiksen JN, Hansen T, et al.. Reliability of clinical ICD-10 schizophrenia diagnoses. Nordic Journal of Psychiatry. 2005, s. 209–12. DOI 10.1080/08039480510027698. PMID 16195122. 
  • McGurk SR, Mueser KT, Feldman K, Wolfe R, Pascaris A. Cognitive training for supported employment: 2–3 year outcomes of a randomized controlled trial.. American Journal of Psychiatry. 2007, s. 437–41. Dostupné online. DOI 10.1176/appi.ajp.164.3.437. PMID 17329468. 
  • Gorczynski P, Faulkner G. Exercise therapy for schizophrenia. Cochrane Database Syst Rev. 2010, s. CD004412. DOI 10.1002/14651858.CD004412.pub2. PMID 20464730. 
  • Tandon R, Keshavan MS, Nasrallah HA. Schizophrenia, "Just the Facts": what we know in 2008 part 1: overview. Schizophrenia Research. 2008, s. 4–19. Dostupné online. DOI 10.1016/j.schres.2008.01.022. PMID 18291627. 
  • LEUCHT, Stefan, Tardy, Magdolna, Komossa, Katja, Heres, Stephan, Kissling, Werner, Salanti, Georgia, Davis, John M. Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis. The Lancet. 1 May 2012. DOI 10.1016/S0140-6736(12)60239-6. 
  • Wahlbeck K, Cheine MV, Essali A. Clozapine versus typical neuroleptic medication for schizophrenia. The Cochrane Database of Systematic Reviews. John Wiley and Sons, Ltd., 2007, s. CD000059. DOI 10.1002/14651858.CD000059. PMID 10796289. 
  • Tandon R, Belmaker RH, Gattaz WF, et al.. World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia. Schizophr. Res.. 2008, s. 20–38. DOI 10.1016/j.schres.2007.11.033. PMID 18243663. 
  • Chwastiak LA, Tek C. The unchanging mortality gap for people with schizophrenia. Lancet. 2009, s. 590–2. DOI 10.1016/S0140-6736(09)61072-2. PMID 19595448. 
  • Ananth J, Parameswaran S, Gunatilake S, Burgoyne K, Sidhom T. Neuroleptic malignant syndrome and atypical antipsychotic drugs. Journal of Clinical Psychiatry. 2004, s. 464–70. DOI 10.4088/JCP.v65n0403. PMID 15119907. 
  • Pharoah F, Mari J, Rathbone J, Wong W. Family intervention for schizophrenia. Cochrane Database Syst Rev. 2010, s. CD000088. DOI 10.1002/14651858.CD000088.pub3. PMID 21154340. 
  • Medalia A, Choi J. Cognitive remediation in schizophrenia.. Neuropsychology Rev. 2009, s. 353–364. Dostupné online. DOI 10.1007/s11065-009-9097-y. PMID 19444614. 
  • Dixon LB, Dickerson F, Bellack AS, et al.. The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements. Schizophr Bull. 2010, s. 48–70. DOI 10.1093/schbul/sbp115. PMID 19955389. 
  • Lynch D, Laws KR, McKenna PJ. Cognitive behavioural therapy for major psychiatric disorder: does it really work? A meta-analytical review of well-controlled trials. Psychol Med. 2010, s. 9–24. DOI 10.1017/S003329170900590X. PMID 19476688. 
  • Jones C, Cormac I, Silveira da Mota Neto JI, Campbell C. Cognitive behaviour therapy for schizophrenia. Cochrane Database Syst Rev. 2004, s. CD000524. DOI 10.1002/14651858.CD000524.pub2. PMID 15495000. 
  • Ruddy R, Milnes D. Art therapy for schizophrenia or schizophrenia-like illnesses.. Cochrane Database Syst Rev. 2005, s. CD003728. Dostupné online. DOI 10.1002/14651858.CD003728.pub2. PMID 16235338. 
  • Ruddy RA, Dent-Brown K. Drama therapy for schizophrenia or schizophrenia-like illnesses.. Cochrane Database Syst Rev. 2007, s. CD005378. Dostupné online. DOI 10.1002/14651858.CD005378.pub2. PMID 17253555. 
  • Marshall M, Rathbone J. Early intervention for psychosis. Cochrane Database Syst Rev. 2006, s. CD004718. DOI 10.1002/14651858.CD004718.pub2. PMID 17054213. 
  • Saha S, Chant D, McGrath J. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?. Arch. Gen. Psychiatry. 2007, s. 1123–31. DOI 10.1001/archpsyc.64.10.1123. PMID 17909124. 
  • Warner R. Recovery from schizophrenia and the recovery model. Curr Opin Psychiatry. 2009, s. 374–80. DOI 10.1097/YCO.0b013e32832c920b. PMID 19417668. 
  • Menezes NM, Arenovich T, Zipursky RB. A systematic review of longitudinal outcome studies of first-episode psychosis. Psychol Med. 2006, s. 1349–62. DOI 10.1017/S0033291706007951. PMID 16756689. 
  • Cohen A, Patel V, Thara R, Gureje O. Questioning an axiom: better prognosis for schizophrenia in the developing world?. Schizophr Bull. 2008, s. 229–44. DOI 10.1093/schbul/sbm105. PMID 17905787. 
  • Palmer BA, Pankratz VS, Bostwick JM. The lifetime risk of suicide in schizophrenia: a reexamination. Archives of General Psychiatry. 2005, s. 247–53. DOI 10.1001/archpsyc.62.3.247. PMID 15753237. 
  • Carlborg A, Winnerbäck K, Jönsson EG, Jokinen J, Nordström P. Suicide in schizophrenia. Expert Rev Neurother. 2010, s. 1153–64. DOI 10.1586/ern.10.82. PMID 20586695. 
  • De Leon J, Diaz FJ. A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophrenia research. 2005, s. 135–57. DOI 10.1016/j.schres.2005.02.010. PMID 15949648. 
  • Keltner NL, Grant JS. Smoke, Smoke, Smoke That Cigarette. Perspectives in Psychiatric Care. 2006, s. 256. DOI 10.1111/j.1744-6163.2006.00085.x. PMID 17107571. 
  • Castle D, Wessely S, Der G, Murray RM. The incidence of operationally defined schizophrenia in Camberwell, 1965–84. The British Journal of Psychiatry. 1991, s. 790–4. DOI 10.1192/bjp.159.6.790. PMID 1790446. 
  • Jablensky A, Sartorius N, Ernberg G, et al.. Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study. Psychological Medicine Monograph Supplement. 1992, s. 1–97. DOI 10.1017/S0264180100000904. PMID 1565705. 
  • Kirkbride JB, Fearon P, Morgan C, et al.. Heterogeneity in incidence rates of schizophrenia and other psychotic syndromes: findings from the 3-center AeSOP study. Archives of General Psychiatry. 2006, s. 250–8. DOI 10.1001/archpsyc.63.3.250. PMID 16520429. 
  • Kirkbride JB, Fearon P, Morgan C, et al.. Neighbourhood variation in the incidence of psychotic disorders in Southeast London. Social Psychiatry and Psychiatric Epidemiology. 2007, s. 438–45. DOI 10.1007/s00127-007-0193-0. PMID 17473901. 

elsevierhealth.com

download.journals.elsevierhealth.com

emedicine.com

  • Larson, Michael. eMedicine [online]. WebMD, 2006-03-30 [cit. 2006-09-27]. Dostupné online. 

kluweronline.com

maastrichtuniversity.nl

nice.org.uk

  • National Collaborating Centre for Mental Health. Schizophrenia: Full national clinical guideline on core interventions in primary and secondary care [PDF]. 2009-03-25 [cit. 2009-11-25]. Dostupné online. 

nih.gov

ncbi.nlm.nih.gov

  • van Os J, Kapur S. Schizophrenia. Lancet. 2009, s. 635–45. Dostupné v archivu pořízeném dne 2013-06-23. DOI 10.1016/S0140-6736(09)60995-8. PMID 19700006.  Archivovaná kopie. xa.yimg.com [online]. [cit. 2014-11-09]. Dostupné v archivu pořízeném z originálu dne 2013-06-23. 
  • Picchioni MM, Murray RM. Schizophrenia. BMJ. 2007, s. 91–5. DOI 10.1136/bmj.39227.616447.BE. PMID 17626963. 
  • Becker T, Kilian R. Psychiatric services for people with severe mental illness across western Europe: what can be generalized from current knowledge about differences in provision, costs and outcomes of mental health care?. Acta Psychiatrica Scandinavica Supplement. 2006, s. 9–16. DOI 10.1111/j.1600-0447.2005.00711.x. PMID 16445476. 
  • Buckley PF, Miller BJ, Lehrer DS, Castle DJ. Psychiatric comorbidities and schizophrenia. Schizophr Bull. 2009, s. 383–402. DOI 10.1093/schbul/sbn135. PMID 19011234. 
  • Kuhn R. Eugen Bleuler's concepts of psychopathology. Tr. Cahn CH. History of Psychiatry. 2004, s. 361–6. DOI 10.1177/0957154X04044603. PMID 15386868. 
  • Stotz-Ingenlath G. Epistemological aspects of Eugen Bleuler's conception of schizophrenia in 1911. Medicine, Health Care and Philosophy. 2000, s. 153–9. Dostupné online. DOI 10.1023/A:1009919309015. PMID 11079343. 
  • Brunet-Gouet E, Decety J. Social brain dysfunctions in schizophrenia: a review of neuroimaging studies. Psychiatry Res. 2006, s. 75–92. DOI 10.1016/j.pscychresns.2006.05.001. PMID 17088049. 
  • Ungvari GS, Caroff SN, Gerevich J. The catatonia conundrum: evidence of psychomotor phenomena as a symptom dimension in psychotic disorders. Schizophr Bull. 2010, s. 231–8. DOI 10.1093/schbul/sbp105. PMID 19776208. 
  • Addington J, Cadenhead KS, Cannon TD, et al.. North American prodrome longitudinal study: a collaborative multisite approach to prodromal schizophrenia research. Schizophrenia Bulletin. 2007, s. 665–72. DOI 10.1093/schbul/sbl075. PMID 17255119. 
  • Amminger GP, Leicester S, Yung AR, et al.. Early onset of symptoms predicts conversion to non-affective psychosis in ultra-high risk individuals. Schizophrenia Research. 2006, s. 67–76. DOI 10.1016/j.schres.2006.02.018. PMID 16677803. 
  • Parnas J, Jorgensen A. Pre-morbid psychopathology in schizophrenia spectrum. British Journal of Psychiatry. 1989, s. 623–7. PMID 2611591. 
  • FAZEL, S, Gulati, G, Linsell, L, Geddes, JR, Grann, M. Schizophrenia and Violence: Systematic Review and Meta-Analysis. Redakce McGrath John. PLoS medicine. August 2009, s. e1000120. DOI 10.1371/journal.pmed.1000120. PMID 19668362. 
  • LARGE, M, Smith, G, Nielssen, O. The relationship between the rate of homicide by those with schizophrenia and the overall homicide rate: a systematic review and meta-analysis. Schizophrenia research. July 2009, s. 123–9. DOI 10.1016/j.schres.2009.04.004. PMID 19457644. 
  • Nordgaard J, Arnfred SM, Handest P, Parnas J. The diagnostic status of first-rank symptoms. Schizophrenia Bulletin. 2008, s. 137–54. DOI 10.1093/schbul/sbm044. PMID 17562695. 
  • Smith T, Weston C, Lieberman J. Schizophrenia (maintenance treatment). Am Fam Physician. 2010, s. 338–9. PMID 20704164. 
  • Drake RJ, Lewis SW. Early detection of schizophrenia. Current Opinion in Psychiatry. 2005, s. 147–50. DOI 10.1097/00001504-200503000-00007. PMID 16639167. 
  • O'Donovan MC, Williams NM, Owen MJ. Recent advances in the genetics of schizophrenia. Hum. Mol. Genet.. 2003, s. R125–33. DOI 10.1093/hmg/ddg302. PMID 12952866. 
  • McLaren JA, Silins E, Hutchinson D, Mattick RP, Hall W. Assessing evidence for a causal link between cannabis and psychosis: a review of cohort studies. Int. J. Drug Policy. 2010, s. 10–9. DOI 10.1016/j.drugpo.2009.09.001. PMID 19783132. 
  • O'Donovan MC, Craddock NJ, Owen MJ. Genetics of psychosis; insights from views across the genome. Hum. Genet.. 2009, s. 3–12. DOI 10.1007/s00439-009-0703-0. PMID 19521722. 
  • Craddock N, Owen MJ. The Kraepelinian dichotomy - going, going... But still not gone. The British Journal of Psychiatry. 2010, s. 92–95. DOI 10.1192/bjp.bp.109.073429. PMID 20118450. 
  • Rosebush PI, MacQueen GM, Clarke JT, Callahan JW, Strasberg PM, Mazurek MF. Late-onset Tay–Sachs disease presenting as catatonic schizophrenia: Diagnostic and treatment issues. Journal of Clinical Psychiatry. 1995, s. 347–53. PMID 7635850. 
  • Crow TJ. The 'big bang' theory of the origin of psychosis and the faculty of language. Schizophrenia Research. 2008, s. 31–52. DOI 10.1016/j.schres.2008.03.010. PMID 18502103. 
  • Van Os J. Does the urban environment cause psychosis?. British Journal of Psychiatry. 2004, s. 287–288. DOI 10.1192/bjp.184.4.287. PMID 15056569. 
  • Selten JP, Cantor-Graae E, Kahn RS. Migration and schizophrenia. Current Opinion in Psychiatry. 2007, s. 111–115. DOI 10.1097/YCO.0b013e328017f68e. PMID 17278906. 
  • Gregg L, Barrowclough C, Haddock G. Reasons for increased substance use in psychosis. Clin Psychol Rev. 2007, s. 494–510. DOI 10.1016/j.cpr.2006.09.004. PMID 17240501. 
  • LARGE, M, Sharma, S, Compton, MT, Slade, T, Nielssen, O. Cannabis Use and Earlier Onset of Psychosis: A Systematic Meta-analysis.. Archives of general psychiatry. 2011 Feb 7. PMID 21300939. 
  • Leweke FM, Koethe D. Cannabis and psychiatric disorders: it is not only addiction. Addict Biol. 2008, s. 264–75. DOI 10.1111/j.1369-1600.2008.00106.x. PMID 18482435. 
  • Moore THM, Zammit S, Lingford-Hughes A et al.. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet. 2007, s. 319–328. DOI 10.1016/S0140-6736(07)61162-3. PMID 17662880. 
  • SEWELL, RA, Ranganathan, M, D'Souza, DC. Cannabinoids and psychosis. International review of psychiatry (Abingdon, England). 2009 Apr, s. 152–62. DOI 10.1080/09540260902782802. PMID 19367509. 
  • HENQUET, C, Di Forti, M, Morrison, P, Kuepper, R, Murray, RM. Gene-Environment Interplay Between Cannabis and Psychosis. Schizophrenia bulletin. 2008 Nov, s. 1111–21. DOI 10.1093/schbul/sbn108. PMID 18723841. 
  • Ben Amar M, Potvin S. Cannabis and psychosis: what is the link?. Journal of psychoactive drugs. 2007 Jun, s. 131–42. DOI 10.1080/02791072.2007.10399871. PMID 17703707. 
  • SAGUD, M, Mihaljević-Peles, A, Mück-Seler, D, Pivac, N, Vuksan-Cusa, B, Brataljenović, T, Jakovljević, M. Smoking and schizophrenia. Psychiatria Danubina. 2009 Sep, s. 371–5. PMID 19794359. 
  • Broome MR, Woolley JB, Tabraham P, et al.. What causes the onset of psychosis?. Schizophr. Res.. 2005, s. 23–34. DOI 10.1016/j.schres.2005.02.007. PMID 16198238. 
  • Bentall RP, Fernyhough C, Morrison AP, Lewis S, Corcoran R. Prospects for a cognitive-developmental account of psychotic experiences. Br J Clin Psychol. 2007, s. 155–73. DOI 10.1348/014466506X123011. PMID 17524210. 
  • Kurtz MM. Neurocognitive impairment across the lifespan in schizophrenia: an update. Schizophrenia Research. 2005, s. 15–26. DOI 10.1016/j.schres.2004.07.005. PMID 15694750. 
  • Cohen AS, Docherty NM. Affective reactivity of speech and emotional experience in patients with schizophrenia. Schizophrenia Research. 2004, s. 7–14. DOI 10.1016/S0920-9964(03)00069-0. PMID 15145465. 
  • Horan WP, Blanchard JJ. Emotional responses to psychosocial stress in schizophrenia: the role of individual differences in affective traits and coping. Schizophrenia Research. 2003, s. 271–83. DOI 10.1016/S0920-9964(02)00227-X. PMID 12591589. 
  • Smith B, Fowler DG, Freeman D,et al.. Emotion and psychosis: links between depression, self-esteem, negative schematic beliefs and delusions and hallucinations. Schizophr. Res.. 2006, s. 181–8. DOI 10.1016/j.schres.2006.06.018. PMID 16857346. 
  • Bell V, Halligan PW, Ellis HD. Explaining delusions: a cognitive perspective. Trends in Cognitive Science. 2006, s. 219–26. DOI 10.1016/j.tics.2006.03.004. PMID 16600666. 
  • Freeman D, Garety PA, Kuipers E, Fowler D, Bebbington PE, Dunn G. Acting on persecutory delusions: the importance of safety seeking. Behav Res Ther. 2007, s. 89–99. DOI 10.1016/j.brat.2006.01.014. PMID 16530161. 
  • Kuipers E, Garety P, Fowler D, Freeman D, Dunn G, Bebbington P. Cognitive, emotional, and social processes in psychosis: refining cognitive behavioral therapy for persistent positive symptoms. Schizophr Bull. 2006, s. S24–31. DOI 10.1093/schbul/sbl014. PMID 16885206. 
  • Green MF. Cognitive impairment and functional outcome in schizophrenia and bipolar disorder. Journal of Clinical Psychiatry. 2006, s. 3–8. PMID 16965182. 
  • Insel TR. Rethinking schizophrenia. Nature. 2010, s. 187–93. DOI 10.1038/nature09552. PMID 21068826. 
  • Laruelle M, Abi-Dargham A, van Dyck CH, et al.. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc. Natl. Acad. Sci. U.S.A.. 1996, s. 9235–40. DOI 10.1073/pnas.93.17.9235. PMID 8799184. 
  • Jones HM, Pilowsky LS. Dopamine and antipsychotic drug action revisited. British Journal of Psychiatry. 2002, s. 271–275. DOI 10.1192/bjp.181.4.271. PMID 12356650. 
  • Konradi C, Heckers S. Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment. Pharmacology and Therapeutics. 2003, s. 153–79. DOI 10.1016/S0163-7258(02)00328-5. PMID 12559388. 
  • Lahti AC, Weiler MA, Tamara Michaelidis BA, Parwani A, Tamminga CA. Effects of ketamine in normal and schizophrenic volunteers. Neuropsychopharmacology. 2001, s. 455–67. DOI 10.1016/S0893-133X(01)00243-3. PMID 11557159. 
  • Coyle JT, Tsai G, Goff D. Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia. Annals of the New York Academy of Sciences. 2003, s. 318–27. DOI 10.1196/annals.1300.020. PMID 14684455. 
  • Tuominen HJ, Tiihonen J, Wahlbeck K. Glutamatergic drugs for schizophrenia: a systematic review and meta-analysis. Schizophrenia Research. 2005, s. 225–34. DOI 10.1016/j.schres.2004.05.005. PMID 15560967. 
  • Jakobsen KD, Frederiksen JN, Hansen T, et al.. Reliability of clinical ICD-10 schizophrenia diagnoses. Nordic Journal of Psychiatry. 2005, s. 209–12. DOI 10.1080/08039480510027698. PMID 16195122. 
  • McGlashan TH. Testing DSM-III symptom criteria for schizotypal and borderline personality disorders. Archives of General Psychiatry. 1987, s. 143–8. PMID 3813809. 
  • McGurk SR, Mueser KT, Feldman K, Wolfe R, Pascaris A. Cognitive training for supported employment: 2–3 year outcomes of a randomized controlled trial.. American Journal of Psychiatry. 2007, s. 437–41. Dostupné online. DOI 10.1176/appi.ajp.164.3.437. PMID 17329468. 
  • Gorczynski P, Faulkner G. Exercise therapy for schizophrenia. Cochrane Database Syst Rev. 2010, s. CD004412. DOI 10.1002/14651858.CD004412.pub2. PMID 20464730. 
  • Tandon R, Keshavan MS, Nasrallah HA. Schizophrenia, "Just the Facts": what we know in 2008 part 1: overview. Schizophrenia Research. 2008, s. 4–19. Dostupné online. DOI 10.1016/j.schres.2008.01.022. PMID 18291627. 
  • Kane JM, Correll CU. Pharmacologic treatment of schizophrenia. Dialogues Clin Neurosci. 2010, s. 345–57. PMID 20954430. 
  • Schultz SH, North SW, Shields CG. Schizophrenia: a review. Am Fam Physician. 2007, s. 1821–9. PMID 17619525. 
  • Wahlbeck K, Cheine MV, Essali A. Clozapine versus typical neuroleptic medication for schizophrenia. The Cochrane Database of Systematic Reviews. John Wiley and Sons, Ltd., 2007, s. CD000059. DOI 10.1002/14651858.CD000059. PMID 10796289. 
  • Tandon R, Belmaker RH, Gattaz WF, et al.. World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia. Schizophr. Res.. 2008, s. 20–38. DOI 10.1016/j.schres.2007.11.033. PMID 18243663. 
  • Chwastiak LA, Tek C. The unchanging mortality gap for people with schizophrenia. Lancet. 2009, s. 590–2. DOI 10.1016/S0140-6736(09)61072-2. PMID 19595448. 
  • Ananth J, Parameswaran S, Gunatilake S, Burgoyne K, Sidhom T. Neuroleptic malignant syndrome and atypical antipsychotic drugs. Journal of Clinical Psychiatry. 2004, s. 464–70. DOI 10.4088/JCP.v65n0403. PMID 15119907. 
  • McEvoy JP. Risks versus benefits of different types of long-acting injectable antipsychotics. J Clin Psychiatry. 2006, s. 15–8. PMID 16822092. 
  • Pharoah F, Mari J, Rathbone J, Wong W. Family intervention for schizophrenia. Cochrane Database Syst Rev. 2010, s. CD000088. DOI 10.1002/14651858.CD000088.pub3. PMID 21154340. 
  • Medalia A, Choi J. Cognitive remediation in schizophrenia.. Neuropsychology Rev. 2009, s. 353–364. Dostupné online. DOI 10.1007/s11065-009-9097-y. PMID 19444614. 
  • Dixon LB, Dickerson F, Bellack AS, et al.. The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements. Schizophr Bull. 2010, s. 48–70. DOI 10.1093/schbul/sbp115. PMID 19955389. 
  • Lynch D, Laws KR, McKenna PJ. Cognitive behavioural therapy for major psychiatric disorder: does it really work? A meta-analytical review of well-controlled trials. Psychol Med. 2010, s. 9–24. DOI 10.1017/S003329170900590X. PMID 19476688. 
  • Jones C, Cormac I, Silveira da Mota Neto JI, Campbell C. Cognitive behaviour therapy for schizophrenia. Cochrane Database Syst Rev. 2004, s. CD000524. DOI 10.1002/14651858.CD000524.pub2. PMID 15495000. 
  • Ruddy R, Milnes D. Art therapy for schizophrenia or schizophrenia-like illnesses.. Cochrane Database Syst Rev. 2005, s. CD003728. Dostupné online. DOI 10.1002/14651858.CD003728.pub2. PMID 16235338. 
  • Ruddy RA, Dent-Brown K. Drama therapy for schizophrenia or schizophrenia-like illnesses.. Cochrane Database Syst Rev. 2007, s. CD005378. Dostupné online. DOI 10.1002/14651858.CD005378.pub2. PMID 17253555. 
  • Marshall M, Rathbone J. Early intervention for psychosis. Cochrane Database Syst Rev. 2006, s. CD004718. DOI 10.1002/14651858.CD004718.pub2. PMID 17054213. 
  • Wu EQ. The economic burden of schizophrenia in the United States in 2002. J Clin Psychiatry. 2005, s. 1122–9. PMID 16187769. 
  • Saha S, Chant D, McGrath J. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?. Arch. Gen. Psychiatry. 2007, s. 1123–31. DOI 10.1001/archpsyc.64.10.1123. PMID 17909124. 
  • Warner R. Recovery from schizophrenia and the recovery model. Curr Opin Psychiatry. 2009, s. 374–80. DOI 10.1097/YCO.0b013e32832c920b. PMID 19417668. 
  • Menezes NM, Arenovich T, Zipursky RB. A systematic review of longitudinal outcome studies of first-episode psychosis. Psychol Med. 2006, s. 1349–62. DOI 10.1017/S0033291706007951. PMID 16756689. 
  • Isaac M, Chand P, Murthy P. Schizophrenia outcome measures in the wider international community. Br J Psychiatry Suppl. 2007, s. s71–7. PMID 18019048. 
  • Cohen A, Patel V, Thara R, Gureje O. Questioning an axiom: better prognosis for schizophrenia in the developing world?. Schizophr Bull. 2008, s. 229–44. DOI 10.1093/schbul/sbm105. PMID 17905787. 
  • Burns J. Dispelling a myth: developing world poverty, inequality, violence and social fragmentation are not good for outcome in schizophrenia. Afr J Psychiatry (Johannesbg). 2009, s. 200–5. PMID 19894340. 
  • Palmer BA, Pankratz VS, Bostwick JM. The lifetime risk of suicide in schizophrenia: a reexamination. Archives of General Psychiatry. 2005, s. 247–53. DOI 10.1001/archpsyc.62.3.247. PMID 15753237. 
  • Carlborg A, Winnerbäck K, Jönsson EG, Jokinen J, Nordström P. Suicide in schizophrenia. Expert Rev Neurother. 2010, s. 1153–64. DOI 10.1586/ern.10.82. PMID 20586695. 
  • De Leon J, Diaz FJ. A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophrenia research. 2005, s. 135–57. DOI 10.1016/j.schres.2005.02.010. PMID 15949648. 
  • Keltner NL, Grant JS. Smoke, Smoke, Smoke That Cigarette. Perspectives in Psychiatric Care. 2006, s. 256. DOI 10.1111/j.1744-6163.2006.00085.x. PMID 17107571. 
  • Castle D, Wessely S, Der G, Murray RM. The incidence of operationally defined schizophrenia in Camberwell, 1965–84. The British Journal of Psychiatry. 1991, s. 790–4. DOI 10.1192/bjp.159.6.790. PMID 1790446. 
  • Kumra S, Shaw M, Merka P, Nakayama E, Augustin R. Childhood-onset schizophrenia: research update. Canadian Journal of Psychiatry. 2001, s. 923–30. PMID 11816313. 
  • Jablensky A, Sartorius N, Ernberg G, et al.. Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study. Psychological Medicine Monograph Supplement. 1992, s. 1–97. DOI 10.1017/S0264180100000904. PMID 1565705. 
  • Kirkbride JB, Fearon P, Morgan C, et al.. Heterogeneity in incidence rates of schizophrenia and other psychotic syndromes: findings from the 3-center AeSOP study. Archives of General Psychiatry. 2006, s. 250–8. DOI 10.1001/archpsyc.63.3.250. PMID 16520429. 
  • Kirkbride JB, Fearon P, Morgan C, et al.. Neighbourhood variation in the incidence of psychotic disorders in Southeast London. Social Psychiatry and Psychiatric Epidemiology. 2007, s. 438–45. DOI 10.1007/s00127-007-0193-0. PMID 17473901. 

ordinace.cz

oxfordreference.com

psychiatrictimes.com

  • Bottas A. Comorbidity: Schizophrenia With Obsessive-Compulsive Disorder. Psychiatric Times. April 15, 2009. Dostupné online. 

psychiatryonline.org

ajp.psychiatryonline.org

  • McGurk SR, Mueser KT, Feldman K, Wolfe R, Pascaris A. Cognitive training for supported employment: 2–3 year outcomes of a randomized controlled trial.. American Journal of Psychiatry. 2007, s. 437–41. Dostupné online. DOI 10.1176/appi.ajp.164.3.437. PMID 17329468. 

psychicus.cz

uzis.cz

web.archive.org

who.int

  • Schizophrenia [online]. World Health Organization, 2011 [cit. 2011-02-27]. Dostupné online. 

yimg.com

xa.yimg.com